These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 32076273)

  • 41. Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment.
    Osborne N; Sundseth R; Burks J; Cao H; Liu X; Kroemer AH; Sutton L; Cato A; Smith JP
    Cancer Immunol Immunother; 2019 Oct; 68(10):1635-1648. PubMed ID: 31549214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma.
    Stromnes IM; Hulbert A; Pierce RH; Greenberg PD; Hingorani SR
    Cancer Immunol Res; 2017 Nov; 5(11):978-991. PubMed ID: 29066497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Profiling the Tumour Immune Microenvironment in Pancreatic Neuroendocrine Neoplasms with Multispectral Imaging Indicates Distinct Subpopulation Characteristics Concordant with WHO 2017 Classification.
    Takahashi D; Kojima M; Suzuki T; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Gotohda N; Ikeda M; Nakatsura T; Ochiai A; Nagino M
    Sci Rep; 2018 Sep; 8(1):13166. PubMed ID: 30177687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis.
    Saranchova I; Han J; Zaman R; Arora H; Huang H; Fenninger F; Choi KB; Munro L; Pfeifer CG; Welch I; Takei F; Jefferies WA
    Sci Rep; 2018 Feb; 8(1):2924. PubMed ID: 29440650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A combination of check-point blockade and α-galactosylceramide elicits long-lasting suppressive effects on murine hepatoma cell growth in vivo.
    Ishii K; Shimizu M; Kogo H; Negishi Y; Tamura H; Morita R; Takahashi H
    Immunobiology; 2020 Jan; 225(1):151860. PubMed ID: 31812347
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blockade of PD-1/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environment.
    Blake SJ; Ching AL; Kenna TJ; Galea R; Large J; Yagita H; Steptoe RJ
    PLoS One; 2015; 10(3):e0119483. PubMed ID: 25741704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis.
    Neumann K; Karimi K; Meiners J; Voetlause R; Steinmann S; Dammermann W; Lüth S; Asghari F; Wegscheid C; Horst AK; Tiegs G
    J Immunol; 2017 Jan; 198(1):128-137. PubMed ID: 27872212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Galectin-9 and PD-L1 antibody blockade combination therapy inhibits tumour progression in pancreatic cancer.
    Li E; Xu J; Chen Q; Zhang X; Xu X; Liang T
    Immunotherapy; 2023 Feb; 15(3):135-147. PubMed ID: 36779368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer.
    Hegde S; Krisnawan VE; Herzog BH; Zuo C; Breden MA; Knolhoff BL; Hogg GD; Tang JP; Baer JM; Mpoy C; Lee KB; Alexander KA; Rogers BE; Murphy KM; Hawkins WG; Fields RC; DeSelm CJ; Schwarz JK; DeNardo DG
    Cancer Cell; 2020 Mar; 37(3):289-307.e9. PubMed ID: 32183949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Group 2 Innate Lymphoid Cells (ILC2s) Are Key Mediators of the Inflammatory Response in Polymicrobial Sepsis.
    Chun TT; Chung CS; Fallon EA; Hutchins NA; Clarke E; Rossi AL; Cioffi WG; Heffernan DS; Ayala A
    Am J Pathol; 2018 Sep; 188(9):2097-2108. PubMed ID: 29935165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune checkpoint blockade immunotherapy to activate anti-tumour T-cell immunity.
    Ramsay AG
    Br J Haematol; 2013 Aug; 162(3):313-25. PubMed ID: 23691926
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
    Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
    J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1.
    Leclerc M; Voilin E; Gros G; Corgnac S; de Montpréville V; Validire P; Bismuth G; Mami-Chouaib F
    Nat Commun; 2019 Jul; 10(1):3345. PubMed ID: 31350404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin-2 immunotherapy action on innate immunity cells in peripheral blood and tumoral tissue of pancreatic adenocarcinoma patients.
    Degrate L; Nobili C; Franciosi C; Caprotti R; Brivio F; Romano F; Leone BE; Trezzi R; Uggeri F
    Langenbecks Arch Surg; 2009 Jan; 394(1):115-21. PubMed ID: 18670745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PD-1 Is Involved in the Dysregulation of Type 2 Innate Lymphoid Cells in a Murine Model of Obesity.
    Oldenhove G; Boucquey E; Taquin A; Acolty V; Bonetti L; Ryffel B; Le Bert M; Englebert K; Boon L; Moser M
    Cell Rep; 2018 Nov; 25(8):2053-2060.e4. PubMed ID: 30463004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming.
    Hundeyin M; Kurz E; Mishra A; Rossi JAK; Liudahl SM; Leis KR; Mehrotra H; Kim M; Torres LE; Ogunsakin A; Link J; Sears RC; Sivagnanam S; Goecks J; Islam KMS; Dolgalev I; Savadkar S; Wang W; Aykut B; Leinwand J; Diskin B; Adam S; Israr M; Gelas M; Lish J; Chin K; Farooq MS; Wadowski B; Wu J; Shah S; Adeegbe DO; Pushalkar S; Vasudevaraja V; Saxena D; Wong KK; Coussens LM; Miller G
    Cancer Discov; 2019 Sep; 9(9):1288-1305. PubMed ID: 31266770
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tissue-specific pathways extrude activated ILC2s to disseminate type 2 immunity.
    Ricardo-Gonzalez RR; Schneider C; Liao C; Lee J; Liang HE; Locksley RM
    J Exp Med; 2020 Apr; 217(4):. PubMed ID: 32031571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer Cell-Intrinsic PD-1 and Implications in Combinatorial Immunotherapy.
    Yao H; Wang H; Li C; Fang JY; Xu J
    Front Immunol; 2018; 9():1774. PubMed ID: 30105035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ICOS regulates the pool of group 2 innate lymphoid cells under homeostatic and inflammatory conditions in mice.
    Paclik D; Stehle C; Lahmann A; Hutloff A; Romagnani C
    Eur J Immunol; 2015 Oct; 45(10):2766-72. PubMed ID: 26249010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-17-producing ST2
    Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
    J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.